Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133668 (US8846711, 12 | US9051321, 12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM50399404 (CHEMBL2178287 | US8623865, 1) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 6.5 | n/a |
Fab Pharma S.A.S. US Patent | Assay Description The assay buffer AB contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 mM... | US Patent US8623865 (2014) BindingDB Entry DOI: 10.7270/Q21R6P6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133671 (US8846711, 15 | US9051321, 15) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM50399405 (CHEMBL2178286 | US8623865, 2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | 6.5 | n/a |
Fab Pharma S.A.S. US Patent | Assay Description The assay buffer AB contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 mM... | US Patent US8623865 (2014) BindingDB Entry DOI: 10.7270/Q21R6P6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133664 (US8846711, 8 | US9051321, 8) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133673 (US8846711, 17 | US9051321, 17) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133676 (US8846711, 20 | US9051321, 20) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 57 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133681 (US8846711, 25 | US8846711, 26 | US9051321, 25) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM9913 (US8846711, 26 | US9051321, 27) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 78 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133683 (US8846711, 28 | US9051321, 28) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133666 (US8846711, 10 | US9051321, 10) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM162339 (US9051321, 11) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133675 (US8846711, 19 | US9051321, 19) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133661 (US8846711, 5 | US9051321, 5) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 250 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133680 (US8846711, 24 | US9051321, 24) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133670 (US8846711, 14 | US9051321, 14) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 340 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM9913 (US8846711, 26 | US9051321, 27) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316890 (US9617262, Compound 3) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 740 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM302048 (US9598407, Compound 4) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 802 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9598407 (2017) BindingDB Entry DOI: 10.7270/Q27083GB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM302046 (US9598407, Compound 2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 821 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9598407 (2017) BindingDB Entry DOI: 10.7270/Q27083GB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM302056 (US9598407, Compound 12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 825 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9598407 (2017) BindingDB Entry DOI: 10.7270/Q27083GB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316888 (US9617262, Compound 1) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 830 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133677 (US8846711, 21 | US9051321, 21) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 870 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM302049 (US9598407, Compound 5) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 927 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9598407 (2017) BindingDB Entry DOI: 10.7270/Q27083GB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133672 (US8846711, 16 | US9051321, 16) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 930 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316902 (US9617262, Compound 17) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 944 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM302053 (US9598407, Compound 9) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 973 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9598407 (2017) BindingDB Entry DOI: 10.7270/Q27083GB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316908 (US9617262, Compound 23) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 998 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316899 (US9617262, Compound 13) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM162329 (US9051321, 6) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
FAB PHARMA S.A.S. US Patent | Assay Description The assay buffer "AB" contained 50 mM ADA (N-(2-acetamido)iminodiacetic acid monosodium salt) pH 6.5, 1 mM dithiothreitol, 0.006% Triton-X100 and 50 ... | US Patent US9051321 (2015) BindingDB Entry DOI: 10.7270/Q2WW7GDG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316924 (US9617262, Compound 40) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316942 (US9617262, Compound 62) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316948 (US9617262, Compound 72) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316931 (US9617262, Compound 47) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316900 (US9617262, Compound 14) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316903 (US9617262, Compound 18) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316936 (US9617262, Compound 53) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316911 (US9617262, Compound 26) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316933 (US9617262, Compound 49) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316925 (US9617262, Compound 41) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316898 (US9617262, Compound 12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316929 (US9617262, Compound 45) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM302077 (US9598407, Compound 34) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9598407 (2017) BindingDB Entry DOI: 10.7270/Q27083GB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM302051 (US9598407, Compound 7) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9598407 (2017) BindingDB Entry DOI: 10.7270/Q27083GB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316928 (US9617262, Compound 44) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316916 (US9617262, Compound 32) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316894 (US9617262, Compound 8) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316897 (US9617262, Compound 11) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316901 (US9617262, Compound 15) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM316910 (US9617262, Compound 25) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Sciences Ireland UC US Patent | Assay Description FabI enzyme inhibition assays were carried out in half-area, 384-well microtitre plates. Compounds were evaluated in 40-μl assay mixtures contai... | US Patent US9617262 (2017) BindingDB Entry DOI: 10.7270/Q21C1ZZ7 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 144 total ) | Next | Last >> |